Application of a Quality by Design‐based approach in development and validation of an RP‐HPLC method for simultaneous estimation of methotrexate and mangiferin in dual drug‐loaded liposomes
Biomedical Chromatography · 2023
DOI: 10.1002/bmc.5648 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2023. Verfasst von Syeda Nashvia Adin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Phytomedicine Laboratory, Department of Pharmacognosy and Phytochemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, …. Hauptthemen laut MEDLINE: Methotrexate, Liposomes. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: DST PURSE Fellowship and Hamdard National Foundation Doctoral Fellowship of Jamia Hamdard.
Abstract (Originalsprache)
The present study delineates the development of a novel rugged and sensitive stability‐indicating risk‐based HPLC method for the concurrent estimation of methotrexate and mangiferin in dual drug‐loaded nanopharmaceuticals based on an analytical QbD approach. Preliminary screening trials along with systemic risk analysis were performed, endeavouring to explicate the critical method attributes, namely pH, percentage orthophosphoric acid content and percentage methanol content, that influence critical quality attributes. Box–Behnken design was utilized for the optimization of the tailing factor as response for methotrexate and mangiferin in short run time. The chromatographic conditions were optimized by performing 17 experimental runs acquired from Design‐Expert software. The chromatographic conditions after the analysis of an optimized zone within the confines of the design space were chosen as mobile phase water–methanol adjusted to pH 3.0 with 0.05% orthophosphoric acid (65:35, v/v) and flow rate 1.0 ml/min using a C 18 analytical column at an isosbestic wavelength of 265 nm. Furthermore, the validation of the optimized method was done in accordance with International Conference on Harmonization guidelines and were reckoned to be in the prescribed limits. The developed RP‐HPLC method has a high degree of practical utility for synchronous detection of methotrexate and mangiferin in pharmaceutical nano‐dosage forms such as protein‐based‐nanoparticles, nanocrystals, polymeric nanoparticles and metallic nanoparticles in in vivo and in vitro studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Phytomedicine Laboratory, Department of Pharmacognosy and Phytochemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.
- Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.
- Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.
ORCID-Profile: Syeda Nashvia Adin, Isha Gupta, Mohd Mujeeb
Förderung
- DST PURSE Fellowship and Hamdard National Foundation Doctoral Fellowship of Jamia Hamdard
Zitieren
APA
Adin, S. N., Gupta, I., Aqil, M., Mujeeb, M., & Najmi, A. K. (2023). Application of a Quality by Design‐based approach in development and validation of an RP‐HPLC method for simultaneous estimation of methotrexate and mangiferin in dual drug‐loaded liposomes. Biomedical Chromatography. https://doi.org/10.1002/bmc.5648
Vancouver
Adin SN, Gupta I, Aqil M, Mujeeb M, Najmi AK. Application of a Quality by Design‐based approach in development and validation of an RP‐HPLC method for simultaneous estimation of methotrexate and mangiferin in dual drug‐loaded liposomes. Biomedical Chromatography. 2023. doi:10.1002/bmc.5648
BibTeX
@article{Adin2023,
author = {Adin, Syeda Nashvia and Gupta, Isha and Aqil, Mohd and Mujeeb, Mohd and Najmi, Abul Kalam},
title = {Application of a Quality by Design‐based approach in development and validation of an RP‐HPLC method for simultaneous estimation of methotrexate and mangiferin in dual drug‐loaded liposomes},
journal = {Biomedical Chromatography},
year = {2023},
doi = {10.1002/bmc.5648}
}
EUVIMED